P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 22 January 2019 | 3:32 pm

HEALTH: IT'S PERSONAL

Abbott recognized as industry leader on Fortune's Most Admired List. more ...

Published 22 January 2019 | 3:09 pm

GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, more ...

Published 22 January 2019 | 1:38 pm

AstraZeneca achieves recognition as one of the 100 Most Sustainable Corporations in the world for second year

AstraZeneca has achieved recognition as one of the 100 Most Sustainable Corporations in the world for the second consecutive year by Corporate Knights (CK), the more ...

Published 21 January 2019 | 10:47 am

GSK announces succession plan to appoint new Chairman

GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that Sir Philip Hampton has informed the Board of his intention to step down as non-executive Chairman and the Board more ...

Published 19 January 2019 | 1:52 am

Press Release Archives

Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line AFP-High more ...

Published 19 January 2019 | 1:28 am

Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line AFP-High Hepatocellular Carcinoma Patients

REACH-2 is the first positive Phase 3 hepatocellular carcinoma trial in a biomarker-selected population known for poor prognosis Pooled data analyses of AFP-High patients in more ...

Published 18 January 2019 | 5:03 pm

Thriving Women, Thriving Communities

Calling All Start-ups Working to Improve Women's Health with Technology more ...

Published 18 January 2019 | 12:54 pm

Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®

- Study did not meet the primary endpoints of overall survival (OS) in the full study population or in the leiomyosarcoma (LMS) sub-population; there was no difference in more ...

Published 18 January 2019 | 10:26 am

Elevating the patient voice in Huntington's Disease

How patient partnership is shaping the future of research and clinical development in Huntington's disease. more ...

Published 18 January 2019 | 8:10 am

Linzess (linaclotide) approved in China for the treatment of irritable bowel syndrome with constipation

AstraZeneca today announced that its partner Ironwood Pharmaceuticals, Inc. has received marketing authorisation from the National Medical Products Administration (NMPA) more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Vienna, September 25 – 28, 2018

Next Annual General Meeting, Vienna, September 25 – 28, 2018